ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Wednesday reported a first-quarter loss of $78.2 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $2.84.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $3.14 per share.
The biopharmaceutical company posted revenue of $1.8 million in the period.
Esperion Therapeutics shares have decreased 32% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $40.60, a decline of 16% in the last 12 months.